Plain-English translation of NCT02869555 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This is a registry — essentially a database — that gathers medical information from patients with multiple myeloma. Researchers at Institut Paoli-Calmettes are building a collection of patient records and health data to help them learn more about how the disease develops, progresses, and responds to different treatments over time.
Multiple myeloma is a serious blood cancer, and doctors need to understand it better to develop more effective treatments and predict which patients might benefit most from certain therapies. By collecting information from thousands of patients in one place, researchers can spot patterns and trends that wouldn't be visible from studying just a few cases.
You likely qualify if…
You likely don't qualify if…
Your participation involves allowing the research team to access and store your medical records and health information in their database. This is an ongoing registry study, so your data may be reviewed by researchers over many years as they conduct studies on multiple myeloma. You won't need to take any new medications or undergo extra procedures beyond your regular cancer care — the researchers simply use information already being collected as part of your treatment.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
France
Enrollment target
~5,000 participants
Started
January 2010
Primary completion
January 2030
Age range
18 Years – 95 Years
Last updated on clinicaltrials.gov in August 2016.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Dominique Genre, MD
Institut Paoli-Calmettes
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.